BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 7, 2002
View Archived Issues
Potential role for CEP-701 in the treatment of acute myeloid leukemia
Read More
Rats expressing DPP-IV show improved glycemic control after treatment with NVP-DPP-728
Read More
Cognitive and behavioral improvements on donepezil in comorbid schizophrenia and dementia
Read More
Patient enrollment completed for phase III clinical trial with Tarceva
Read More
Xechem acquires exclusive worldwide rights to Niprisan
Read More
Collaboration agreement announced for the development of emphysema treatment
Read More
AVI-4126 completes phase Ib polycystic kidney disease trial
Read More
Forest submits memantine NDA for Alzheimer's disease
Read More
Aventis and ViroPharma terminate Picovir agreement
Read More
Biomira updates recent progress of Theratope and BLP25
Read More
Modex advances Allox through early-stage clinical testing
Read More
Novel anti-HIV agents presented by AIDS Care Pharma
Read More
New vasopressin V1a/V2 modulators for renal failure and hypertension
Read More
Novel prostaglandin D2 antagonists included in Merck Frosst patent
Read More
Merck & Co. researchers identify new alphavbeta3/alphavbeta5 integrin antagonists
Read More
Novel NPY5 modulators in early development at Neurogen
Read More
New antiarrhythmic Kv1.5 channel blockers prepared and tested at Aventis
Read More